Research project overview ALICE: A randomized placebo-controlled phase II study evaluating atezolizumab combined with immunogenic chemotherapy in patients with metastatic triple-negative breast cancer REPORT: Reirradiation and PD-1 blockade on recurrent squamous cell head and neck tumors ICON: A randomized phase IIb study evaluating immunogenic chemotherapy combined with double immunological checkpoint blockade in patients with metastatic luminal B breast cancer
Rim S, Sakkestad ST, Zhou F, Gullaksen SE, Skavland J, Chauhan SK, Steinsland H, Hanevik K (2023) Dynamics of circulating lymphocytes responding to human experimental enterotoxigenic Escherichia coli infection Eur J Immunol, 53 (8), e2250254 DOI 10.1002/eji.202250254, PubMed 37102399 Chauhan SK, Bartolomé Casado R, Landsverk OJB, Johannessen H, Phung D, Nilsen HR, Sætre F, Jahnsen J, Horneland R, Yaqub S, Aandahl EM, Lundin KEA, Bækkevold ES, Jahnsen FL (2023) Human small intestine contains 2 functionally distinct regulatory T-cell subsets J Allergy Clin Immunol, 152 (1), 278-289.e6 DOI 10.1016/j.jaci.2023.02.030, PubMed 36893861 Beck C, Casey NP, Persiconi I, Moharrami NN, Sike A, Jin Y, Kyte JA (2023) Development of a TGFβ-IL-2/15 Switch Receptor for Use in Adoptive Cell Therapy Biomedicines, 11 (2) DOI 10.3390/biomedicines11020459, PubMed 36830995